What is Nonalcoholic fatty liver disease ?(NAFLD)?

Nonalcoholic Fatty Liver Disease (NAFLD) is a condition where excess fat builds up in the liver of individuals who drink little to no alcohol. It represents a spectrum of liver disorders that range from simple fat accumulation (steatosis) to inflammation and liver damage. NAFLD is one of the most common liver conditions worldwide and is closely linked with obesity, insulin resistance, type 2 diabetes, and high cholesterol.

While simple steatosis is generally benign, in some individuals, the disease can progress to a more severe form called Nonalcoholic Steatohepatitis (NASH), which may lead to fibrosis, cirrhosis, or even liver cancer.

Is Nonalcoholic fatty liver disease common?

Yes. NAFLD affects approximately 25–30% of adults globally, with higher prevalence in people who are overweight, have metabolic syndrome, or have type 2 diabetes. It is increasingly being recognized in children and adolescents due to rising obesity rates.

Can Nonalcoholic fatty liver disease be cured?

There is currently no specific medication to cure NAFLD, but the condition can often be reversed or stabilized through lifestyle changes such as weight loss, healthy diet, and regular physical activity. Early diagnosis and management are key to preventing progression to more severe liver disease.